Carsten Carlberg | |
---|---|
Born | |
Nationality | German |
Alma mater | Free University of Berlin |
Known for | Research in nuclear hormone signaling & Vitamin D |
Scientific career | |
Fields | Nutrigenomics |
Institutions | Institute of Animal Reproduction and Food Research, Olsztyn |
Doctoral advisor | Burghardt Wittig |
Carsten Carlberg (born December 13, 1963, married to Eunike Velleuer-Carlberg, since July 26, 2023) is a German biochemist. He is professor of nutrigenomics at the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences in Olsztyn, Poland.
Carlberg was born in Hamburg, Germany. He attended school at Bremen, Germany, graduating in 1981 with Abitur at the Gymnasium an der Bördestrasse. [1] From 1982 to 1987, he studied Physics and Biochemistry at the Free University of Berlin, Germany, finishing with a diploma in biochemistry. Thereafter he worked in the team of Burghardt Wittig and in 1989 received his PhD (Dr. rer. nat.) for his studies on the interaction of polymerases with DNA secondary structures at the Free University of Berlin.
From 1989 to 1992, Carlberg was a post-doctoral fellow in the team of Willi Hunziker at the Central Research Units of Hoffmann-La Roche in Basel, Switzerland, and started his work on the gene regulation of Vitamin D. From 1992 to 1997, he worked in the Dermatology Department of Jean-Hilaire Saurat at the University of Geneva, where he continued his studies of gene regulation by nuclear receptors. In 1997, Carlberg received his Habilitation at the University of Düsseldorf, Germany, and was research group leader in the Department of Physiological Chemistry of Helmut Sies.
In 2000, Carlberg was appointed full professor of biochemistry [2] at the University of Kuopio, which in 2010 merged with the University of Joensuu to form the University of Eastern Finland. In 2006, he took a second affiliation at the University of Luxembourg, in order to create the Master program in Integrated Systems Biology there. He was later dismissed to protect the university’s reputation after the retraction of two papers co-written with a former student, Tatajana Degenhardt, from his group in Finland. [3] An Ad Hoc Ethical Committee found Ms. Degenhardt guilty of manipulating research data, resulting in the revocation of her doctoral degree. While no evidence of negligence or fraud was found against Carlberg, he was criticized for a lack of supervision over Ms. Degenhardt. [4] From 2008 to 2013 he was one of 4 principal investigators at the Finnish Center of Excellence in Cardiovascular Diseases and Type 2 Diabetes Research. [5]
Carlberg's research is focused on epigenetics with special focus on Vitamin D. [2]
Over 250 of his publications [6] are listed in the Science Citation Index. These have been cited more than 12,000 times, according to ResearcherID. Carsten Carlberg's h-index is 61.
Carsten Carlberg published textbooks on "Nutrigenomics,", [7] "Mechanisms of Gene Regulation", [8] and "Human Epigenomics". [9]
The University of Oulu is one of the largest universities in Finland, located in the city of Oulu. It was founded on July 8, 1958. The university has around 13,000 students and 2,900 staff. 21 International Master's Programmes are offered at the university. The university is often ranked as one of the best universities in Finland and in the top 400 worldwide.
Saghir Akhtar is professor of pharmacology in the College of Medicine, Qatar University, and editor in chief of the Journal of Drug Targeting.
The Max Planck Institute of Molecular Plant Physiology is a German research institute for molecular plant physiology, based in the Golm district of Potsdam, Brandenburg. Founded on 1 January 1994, the MPIMP focuses on the study of the dynamics of plant metabolism and how that relates to the entire plant system. The institution is one of the 80 institutes in the Max Planck Society (Max-Planck-Gesellschaft).
The Pennington Biomedical Research Center is a health science-focused research center in Baton Rouge, Louisiana. It is part of the Louisiana State University System and conducts clinical, basic, and population science research. It is the largest academically-based nutrition research center in the world, with the greatest number of obesity researchers on faculty. The center's over 500 employees occupy several buildings on the 222-acre (0.90 km2) campus. The center was designed by the Baton Rouge architect John Desmond.
The University of Eastern Finland is a university in Finland founded in 2010 with campuses in Joensuu and Kuopio.
Pyruvate dehydrogenase kinase isoform 2 (PDK2) also known as pyruvate dehydrogenase lipoamide kinase isozyme 2, mitochondrial is an enzyme that in humans is encoded by the PDK2 gene. PDK2 is an isozyme of pyruvate dehydrogenase kinase.
BIOBASE is an international bioinformatics company headquartered in Wolfenbüttel, Germany. The company focuses on the generation, maintenance, and licensing of databases in the field of molecular biology, and their related software platforms.
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.
Joachim Wilhelm "Jo" Messing was a German-American biologist who was a professor of molecular biology and the fourth director of the Waksman Institute of Microbiology at Rutgers University.
The National Institute of Genomic Medicine is one of Mexico's twelve national institutes under the Secretariat of Health. The institute was founded in 2004, with its official headquarters built eight years later. INMEGEN is dedicated to the development of genomic medicine for the Mexican population. The institute carried out research projects aim to improve healthcare through prevention and medical care related to oncogenomics, nutrigenomics and pharmacogenomics. INMEGEN also studies metabolic, cardiovascular, autoimmune and infectious diseases. INMEGEN collaborates with other Mexican and international institutions for the development of different projects. The current director of the institution is Francisco Xavier Soberón.
Carl Ronald Kahn is an American physician and scientist, best known for his work with insulin receptors and insulin resistance in diabetes and obesity. He is the Chief Academic Officer at Joslin Diabetes Center, the Mary K. Iacocca Professor of Medicine at Harvard Medical School and a member of the National Academy of Sciences since 1999.
Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves. Diabetes accounts for approximately 4.2 million deaths every year, with an estimated 1.5 million caused by either untreated or poorly treated diabetes.
Jean-Claude Tardif is the Director of the Research Center at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. He received his medical degree (MD) in 1987 from the University of Montreal and specialized in cardiology and research in Montreal and Boston until 1994. Dr. Tardif holds the Canada Research Chair in personalized medicine and the University of Montreal endowed research chair in atherosclerosis. He is also the Scientific Director of the Montreal Health Innovations Coordinating Center (MHICC).
Levon Michael Khachigian is an Australian medical research scientist notable for his work in vascular cell and molecular biology. He is a Professor in the Faculty of Medicine at the University of New South Wales.
Sanjeev Anant Galande is an Indian cell biologist, epigeneticist, academic, former Chair of Biology and the Dean of Research and Development at the Indian Institute of Science Education and Research, Pune. He heads the Laboratory of Chromatin Biology and Epigenetics at the Indian Institute of Science Education and Research, Pune. He is the founder of the Centre of Excellence in Epigenetics at IISER Pune and is known for his studies on higher-order chromatin architecture and how it influences spatiotemporal changes in gene expression. He is an elected fellow of the Indian National Science Academy and the Indian Academy of Sciences and a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2010, for his contributions to biological sciences.
Markku Laakso is a Finnish professor of medicine and a type 2 diabetes researcher. He was awarded the Matti Äyräpää Prize in 2007, the Kelly West Award in 2008, and the Finnish Science Award in 2015.
Sónia Maria Campos Soares da Rocha, usually referred to as Professor Sónia Rocha, is a Portuguese cell biologist who holds a personal chair in biochemistry at the University of Liverpool, where she is the head of the Department of Biochemistry. Rocha runs an active multidisciplinary cell signaling research group studying hypoxia, and focused around transcription factors such as Hypoxia-inducible factors and NF-κB. Her laboratory is currently based in the Institute of Integrative Biology.
Bernard Zinman is a Canadian clinical and research endocrinologist, whose research at the University of Toronto focuses on type 1 and type 2 diabetes. He directed the Mount Sinai Hospital Leadership Sinai Centre for Diabetes and the Banting and Best Diabetes Centre. In 2019, he was appointed as an Officer to the Order of Canada in recognition of his scientific contributions, including the development of preventative therapies for diabetes.
Thomas Kietzmann is a German physician and biochemist. He is a professor for biochemistry at the University of Oulu in Finland.
Shaodong Guo is a Chinese-American nutrition scientist, academic, and diabetes researcher. He is a professor in nutrition and medicine at the Department of Nutrition of Texas A&M University. He has been a senior editor for Journal of Endocrinology and Journal of Molecular Endocrinology.